Improved Glycemic Control in a Patient Group Performing 7-Point Profile Self-Monitoring of Blood Glucose and Intensive Data Documentation: An Open-Label, Multicenter, Observational Study
Open accessAbstract
INTRODUCTION: Regular self-monitoring of blood glucose (SMBG) is recommended as an integral part of therapy for all patients with diabetes treated with insulin. In the current study, the effects on glycemic control of taking 7-point SMBG profiles and using a diabetes management system (DMA) on a smartphone were investigated. METHODS: SMBG system. HbA1c was measured at regular visits to the study sites. Patients reviewed and managed their data as well as their treatment on their own and there were no further assistance or treatment recommendations. Adverse events (AEs) were recorded throughout. RESULTS: Overall, mean (SD) change from baseline in HbA1c at week 12 was -0.46 (0.57)% [-5 (6) mmol/mol (p < 0.0001)]. The change in HbA1c was observed in patients with T1DM [-0.27 (0.45)% (-3 [5] mmol/mol; p = 0.0063)] and T2DM [-0.65 (0.62)% (-7 [7] mmol/mol; p < 0.0001)]. The change in HbA1c was not correlated with an increased number of hypoglycemic events (blood glucose less than 55 mg/dL). The majority of AEs were symptomatic hypoglycemic events (42 events; nine patients). CONCLUSIONS: Glycemic control can be improved, without receiving any recommendations or advice on insulin dose, by performing daily 7-point SMBG profiles and using electronic documentation with a smartphone app. These results must be confirmed in a larger controlled trial, but they already strengthen the importance of structured SMBG in diabetes therapy. FUNDING: Sanofi.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Researchers evaluated a range of measures that aligned with their target chronic condition, such as blood glucose, weight, symptoms, patient-reported outcomes, diary entries, and steps.
“Researchers evaluated a range of measures that aligned with their target chronic condition, such as blood glucose [56,60,61,64,73], weight [56,73,74], symptoms [66,68,69], patient-reported outcomes [38,46,52,65,71], diary entries [47,66], and steps [51].”
From A Library of Analytic Indicators to Evaluate Effective Engagement with Consumer mHealth Apps for Chronic Conditions: Scoping Review (2019) · cites this paper as [61]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Polonsky, W. H., Fisher, L., Schikman, C. H., Hinnen, D. A., Parkin, C. G., Jelsovsky, Z., Petersen, B., Schweitzer, M., & Wagner, R. S. (2011) · Diabetes Care · doi:10.2337/dc10-1732 · Cited by 429 · see citing works
Schütt, M., Kern, Krause, U., Busch, Dapp, A., Grziwotz, Mayer, I., Rosenbauer, Wagner, C., Zimmermann, et al. (2006) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2006-924152 · Cited by 218 · see citing works
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s008 · Cited by 216 · see citing works
Longitudinal study of new and prevalent use of self-monitoring of blood glucose
Karter, A. J., Parker, M. M., Moffet, H. H., Spence, M. M., Chan, J., Ettner, S. L., & Selby, J. V. (2006) · Diabetes Care · doi:10.2337/dc06-2073 · Cited by 139 · see citing works
Bosi, E., Scavini, M., Ceriello, A., Cucinotta, D., Tiengo, A., Marino, R., Bonizzoni, E., Giorgino, F., & on behalf of the PRISMA Study Group (2013) · Diabetes Care · doi:10.2337/dc13-0092 · Cited by 105 · see citing works
Rao, A. V., Hou, P., Golnik, T., Flaherty, J., & Vu, S. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400426 · Cited by 80 · see citing works
Kempf, K., Kruse, J., & Martin, S. (2012) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2011.0116 · Cited by 48 · see citing works
Bailey, T. S., Wallace, J. F., Pardo, S. A., Warchal-Windham, M. E., Harrison, B., Morin, R., & Christiansen, M. P. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816680829 · Cited by 46 · see citing works
Clements, M. A., & Staggs, V. S. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817691302 · Cited by 42 · see citing works
Garg, S. K., Shah, V. N., Aktürk, H. K., Beatson, C. R., & Snell‐Bergeon, J. K. (2017) · Diabetes Therapy · doi:10.1007/s13300-017-0272-5 · Cited by 40 · see citing works
BAJAJ, H. S., Venn, K., Ye, C., & Aronson, R. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0182 · Cited by 34 · see citing works
Christiansen, M. P., Greene, C., Pardo, S. A., Warchal-Windham, M. E., Harrison, B., Morin, R., & Bailey, T. S. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817691301 · Cited by 31 · see citing works
Minder, A. E., Albrecht, D., Schäfer, J., & Zulewski, H. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.12.024 · Cited by 28 · see citing works
Harvey, C., Koubek, R., Bégat, V., & Jacob, S. (2016) · Journal of Diabetes Science and Technology · doi:10.1177/1932296816658058 · Cited by 19 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Pham, Q., Graham, G., Carrion, C., Morita, P. P., Seto, E., Stinson, J. N., & Cafazzo, J. A. (2019) · JMIR mHealth and uHealth · doi:10.2196/11941 · Cited by 131 · see citing works
- Authors
- Sieber, J., Flacke, F., Link, M., Haug, C., & Freckmann, G.
- Affiliations
- Sanofi (Germany) (DE)
- Universität Ulm (DE)
- Corresponding author
- Sieber, Jochen
- Venue
- Diabetes Therapy
- Published
- 2017-09-14
- Volume
- 8
- Issue
- 5
- Pages
- 1079-1085
- ISSN
- 1869-6953 (ISSN-L)
- 1869-6961
- PMC
- PMC5630561
- OpenAlex
- W2754307489
- Cited by
- 11
- References
- 15
- Citations by year
- 2025: 1 · 2023: 1 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 1
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Diabetes Therapy (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Funders
- Sanofi
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- self-monitoring of blood glucose, glycemic control, HbA1c, insulin-treated diabetes, type 1 diabetes, type 2 diabetes, hypoglycemia, adverse events
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
